309 related articles for article (PubMed ID: 26632666)
1. PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype.
Duan S; Yuan G; Liu X; Ren R; Li J; Zhang W; Wu J; Xu X; Fu L; Li Y; Yang J; Zhang W; Bai R; Yi F; Suzuki K; Gao H; Esteban CR; Zhang C; Izpisua Belmonte JC; Chen Z; Wang X; Jiang T; Qu J; Tang F; Liu GH
Nat Commun; 2015 Dec; 6():10068. PubMed ID: 26632666
[TBL] [Abstract][Full Text] [Related]
2. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
[TBL] [Abstract][Full Text] [Related]
3. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
4. Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration.
Davies EM; Kong AM; Tan A; Gurung R; Sriratana A; Bukczynska PE; Ooms LM; McLean CA; Tiganis T; Mitchell CA
Oncogene; 2015 Jul; 34(28):3711-27. PubMed ID: 25241900
[TBL] [Abstract][Full Text] [Related]
5. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
[TBL] [Abstract][Full Text] [Related]
6. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
7. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
[TBL] [Abstract][Full Text] [Related]
8. Decreased nuclear Pten in neural stem cells contributes to deficits in neuronal maturation.
Kang SC; Jaini R; Hitomi M; Lee H; Sarn N; Thacker S; Eng C
Mol Autism; 2020 Jun; 11(1):43. PubMed ID: 32487265
[TBL] [Abstract][Full Text] [Related]
9. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma extracellular vesicles induce the tumour-promoting transformation of neural stem cells.
Wang J; Liu J; Sun G; Meng H; Wang J; Guan Y; Yin Y; Zhao Z; Dong X; Yin S; Li H; Cheng Y; Wu H; Wu A; Yu X; Chen L
Cancer Lett; 2019 Dec; 466():1-12. PubMed ID: 31521694
[TBL] [Abstract][Full Text] [Related]
11. The protein phosphatase activity of PTEN is essential for regulating neural stem cell differentiation.
Lyu J; Yu X; He L; Cheng T; Zhou J; Cheng C; Chen Z; Cheng G; Qiu Z; Zhou W
Mol Brain; 2015 Apr; 8():26. PubMed ID: 25927309
[TBL] [Abstract][Full Text] [Related]
12. Failure of the PTEN/aPKC/Lgl Axis Primes Formation of Adult Brain Tumours in
Paglia S; Sollazzo M; Di Giacomo S; de Biase D; Pession A; Grifoni D
Biomed Res Int; 2017; 2017():2690187. PubMed ID: 29445734
[TBL] [Abstract][Full Text] [Related]
13. Tangeretin induces cell cycle arrest and apoptosis through upregulation of PTEN expression in glioma cells.
Ma LL; Wang DW; Yu XD; Zhou YL
Biomed Pharmacother; 2016 Jul; 81():491-496. PubMed ID: 27261630
[TBL] [Abstract][Full Text] [Related]
14. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
15. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.
Shingu T; Ho AL; Yuan L; Zhou X; Dai C; Zheng S; Wang Q; Zhong Y; Chang Q; Horner JW; Liebelt BD; Yao Y; Hu B; Chen Y; Fuller GN; Verhaak RG; Heimberger AB; Hu J
Nat Genet; 2017 Jan; 49(1):75-86. PubMed ID: 27841882
[TBL] [Abstract][Full Text] [Related]
16. PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.
Gont A; Hanson JE; Lavictoire SJ; Parolin DA; Daneshmand M; Restall IJ; Soucie M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA
Oncotarget; 2013 Aug; 4(8):1266-79. PubMed ID: 23907540
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness.
de la Iglesia N; Konopka G; Lim KL; Nutt CL; Bromberg JF; Frank DA; Mischel PS; Louis DN; Bonni A
J Neurosci; 2008 Jun; 28(23):5870-8. PubMed ID: 18524891
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
[TBL] [Abstract][Full Text] [Related]
19. PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.
Qian X; Li X; Shi Z; Xia Y; Cai Q; Xu D; Tan L; Du L; Zheng Y; Zhao D; Zhang C; Lorenzi PL; You Y; Jiang BH; Jiang T; Li H; Lu Z
Mol Cell; 2019 Nov; 76(3):516-527.e7. PubMed ID: 31492635
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.
Zorniak M; Clark PA; Leeper HE; Tipping MD; Francis DM; Kozak KR; Salamat MS; Kuo JS
Clin Cancer Res; 2012 Jul; 18(13):3628-36. PubMed ID: 22589395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
